These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32459885)

  • 1. Pharmacokinetic Comparison of Capsule and Tablet Formulations of Opicapone in Healthy Japanese Subjects: Phase 1 Study.
    Nomoto M; Takeda A; Iwai K; Nishimura A; Hattori N
    Clin Pharmacol Drug Dev; 2021 Feb; 10(2):173-179. PubMed ID: 32459885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Opicapone Tablets on Levodopa and 3-O-Methyldopa Pharmacokinetics in Healthy Japanese Subjects: Phase 1 Study.
    Nomoto M; Takeda A; Iwai K; Nishimura A; Hattori N
    Clin Pharmacol Drug Dev; 2021 Feb; 10(2):180-189. PubMed ID: 32416054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of catechol-O-methyltransferase in the cynomolgus monkey by opicapone after acute and repeated administration.
    Kitajima T; Mizote S; Bonifácio MJ; Umemura T; Yoneda K; Moser P; Soares-da-Silva P; Tanaka M
    Neuropharmacology; 2018 Dec; 143():282-288. PubMed ID: 30290160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opicapone pharmacokinetics and pharmacodynamics comparison between healthy Japanese and matched white subjects.
    Falcão A; Rocha JF; Santos A; Nunes T; Soares-da-Silva P
    Clin Pharmacol Drug Dev; 2016 Mar; 5(2):150-61. PubMed ID: 27138028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of opicapone, a third-generation COMT inhibitor, after single and multiple oral administration: A comparative study in the rat.
    Gonçalves D; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Toxicol Appl Pharmacol; 2017 May; 323():9-15. PubMed ID: 28322896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of moderate liver impairment on the pharmacokinetics of opicapone.
    Rocha JF; Santos A; Falcão A; Lopes N; Nunes T; Pinto R; Soares-da-Silva P
    Eur J Clin Pharmacol; 2014 Mar; 70(3):279-86. PubMed ID: 24271646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations in healthy Chinese adult male volunteers: a randomized sequence, open-label, two-period crossover study.
    Zou JJ; Ji HJ; Wu DW; Yao J; Hu Q; Xiao DW; Wang GJ
    Clin Ther; 2008 Sep; 30(9):1651-7. PubMed ID: 18840370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study.
    Pinto R; l'Hostis P; Patat A; Homery MC; Falcão A; Nunes T; Rocha JF; Soares-da-Silva P
    Clin Pharmacol Drug Dev; 2015 Nov; 4(6):454-62. PubMed ID: 27137718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects.
    Rocha JF; Almeida L; Falcão A; Palma PN; Loureiro AI; Pinto R; Bonifácio MJ; Wright LC; Nunes T; Soares-da-Silva P
    Br J Clin Pharmacol; 2013 Nov; 76(5):763-75. PubMed ID: 23336248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor.
    Almeida L; Rocha JF; Falcão A; Palma PN; Loureiro AI; Pinto R; Bonifácio MJ; Wright LC; Nunes T; Soares-da-Silva P
    Clin Pharmacokinet; 2013 Feb; 52(2):139-51. PubMed ID: 23248072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
    Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
    Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opicapone: A Review in Parkinson's Disease.
    Scott LJ
    Drugs; 2016 Sep; 76(13):1293-1300. PubMed ID: 27498199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single- and multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of opicapone, a novel COMT inhibitor, in rat.
    Gonçalves D; Alves G; Fortuna A; Bonifácio MJ; Soares-da-Silva P; Falcão A
    Neuropharmacology; 2017 Oct; 125():146-155. PubMed ID: 28734868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers.
    Pan L; Belloni P; Ding HT; Wang J; Rubino CM; Putnam WS
    Adv Ther; 2017 Sep; 34(9):2071-2082. PubMed ID: 28808905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and bioequivalence studies of choline alfoscerate tablet comparing with soft gelatin capsule in healthy male volunteers.
    Min MH; Park JH; Hur JH; Shin HC; Cho Y; Kim DD
    Drug Des Devel Ther; 2019; 13():1049-1058. PubMed ID: 31040642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers.
    Liu MY; Wang S; Yao WF; Wu HZ; Meng SN; Wei MJ
    Clin Ther; 2009 Apr; 31(4):784-92. PubMed ID: 19446151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic drug evaluation of opicapone for the treatment of Parkinson's disease.
    Svetel M; Tomić A; Kresojević N; Kostić V
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):353-360. PubMed ID: 29345156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.